Exagen
(NASDAQ) XGN
Exagen Financials at a Glance
Market Cap
$73.60M
Revenue (TTM)
$66.58M
Net Income (TTM)
$19.95M
EPS (TTM)
$-0.92
P/E Ratio
-3.33
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$3.07
Volume
7,052
Open
$2.95
Price
$3.07
Volume
7,052
Open
$2.95
Previous Close
$3.07
Daily Range
$2.95 - $3.08
52-Week Range
$2.59 - $12.23
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$3.07
Volume
7,052
Open
$2.95
Previous Close
$3.07
Daily Range
$2.95 - $3.08
52-Week Range
$2.59 - $12.23
XGN News
XGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Exagen
Industry
Biotechnology
Sector
Health CareEmployees
216
CEO
John Aballi, MBA
Website
www.exagen.comHeadquarters
Vista, CA 92081, US
XGN Financials
Key Financial Metrics (TTM)
Gross Margin
58%
Operating Margin
-21%
Net Income Margin
-30%
Return on Equity
-148%
Return on Capital
-32%
Return on Assets
-34%
Earnings Yield
-30.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$73.60M
Shares Outstanding
24.05M
Volume
7.05K
Short Interest
0.00%
Avg. Volume
456.99K
Financials (TTM)
Gross Profit
$38.80M
Operating Income
$14.07M
EBITDA
$11.95M
Operating Cash Flow
$13.63M
Capital Expenditure
$641.00K
Free Cash Flow
$14.27M
Cash & ST Invst.
$32.22M
Total Debt
$5.40M
Exagen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.63M
+21.8%
Gross Profit
$9.21M
+8.6%
Gross Margin
55.35%
N/A
Market Cap
$73.60M
N/A
Market Cap/Employee
$352.17K
N/A
Employees
209
N/A
Net Income
$4.67M
-24.2%
EBITDA
$4.38M
-57.9%
Quarterly Fundamentals
Net Cash
$4.55M
+570.0%
Accounts Receivable
$10.86M
+38.5%
Inventory
$0.00
N/A
Long Term Debt
$24.66M
+14.8%
Short Term Debt
$3.00M
+97.8%
Return on Assets
-34.39%
N/A
Return on Invested Capital
-32.08%
N/A
Free Cash Flow
$3.06M
-1508.8%
Operating Cash Flow
$3.01M
-930.0%